Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
131i-tm-601 (2 trials)
Adenocarcinoma (Phase 1)
Glioma (Phase 1)
Melanoma (Phase 2)
Trials (2 total)
Trial APIs (1 total)